| Identification | |
| Name: | Naproxen sodium |
| Synonyms: | 2-Naphthaleneaceticacid, 6-methoxy-a-methyl-, sodiumsalt, (S)-;2-Naphthaleneacetic acid, 6-methoxy-a-methyl-, sodium salt, L-(-)- (8CI);(2S)-2-(6-Methoxy-2-naphthyl)propanoic acid sodium salt;Aflaxen;Agilxen;Aleve;Anaprox;Anaprox DS;Apranax;Apraxin;Dafloxen;Duk-F;Flanax;Flanax Forte;Gynestrel;Lefaine;Licorax;Miranax;Naprelan;Naprogesic; |
| CAS: | 26159-34-2 |
| EINECS: | 247-486-2 |
| Molecular Formula: | C14H13O3.Na |
| Molecular Weight: | 252.24 |
| InChI: | InChI=1/C14H14O3.Na/c1-9(14(15)16)10-3-4-12-8-13(17-2)6-5-11(12)7-10;/h3-9H,1-2H3,(H,15,16);/q;+1/p-1/t9-;/m0./s1 |
| Molecular Structure: |  |
| Properties | |
| Transport: | 3249 |
| Density: | == |
| Solubility: | Slightly soluble in ether; soluble in methanol, chloroform Soluble in 25 parts ethanol (96%), 20 parts methanol, 15 parts chloroform, 40 parts ether. Practically insoluble in water Practically insoluble in water and freely soluble in alcohol. In water, 15.9 mg/L at 25 deg C |
| Appearance: | white powder |
| Specification: |
?Naproxen sodium , its CAS NO. is 26159-34-2, the synonyms are (-)-Sodium (S)-6-methoxy-alpha-methyl-2-naphthaleneacetate ; 2-Naphthaleneacetic acid, 6-methoxy-alpha-methyl-, sodium salt, (S)- ; 2-Naphthaleneacetic acid, 6-methoxy-alpha-methyl-, sodium salt, L-(-)- ; Sodium (-)-2-(6-methoxy-2-naphthyl)propionate . |
| Packinggroup: | III |
| Biological Activity: | Non-selective cyclooxygenase (COX) inhibitor that displays anti-inflammatory, antipyretic and analgesic effects. Has a neuroprotective role against colchicine-induced cognitive impairment and oxidative stress. |
| Color: | Crystals from acetone-hexane White to off-white crystalline powder White to creamy white, crystalline powder; soluble in water and sparingly soluble in alcohol. /Naproxen sodium/ |
| Usage: | Naproxen sodium (CAS NO.26159-34-2) is a non-steroidal anti-inflammatory drug commonly used for fever, inflammation the reduction of moderate to severe pain,and stiffness caused by conditions such as psoriatic arthritis, gout, ankylosing spondylitis,osteoarthritis, rheumatoid arthritis, and the treatment of primary dysmenorrhea. |
| Safety Data | |
 |
|
